Regulating drivers with epilepsy in Maryland: Results of the application of a United States consensus guideline

Brandy B. Ma, John Bloch, Allan Krumholz, Jennifer L. Hopp, Perry Foreman, Carl A. Soderstrom, Mary A. Scottino, Martha Matsumoto, Gregory Krauss

Research output: Contribution to journalArticle

Abstract

Objective: Driving regulations for people with seizures vary widely throughout the United States and the world. Maryland updated their guidelines in 2003 to reflect those of a U.S. consensus guideline requiring a minimum 3-month seizure-free period as well as an individual risk assessment by a Medical Advisory Board (MAB). This retrospective study provides the first analysis of outcomes after the implementation of the consensus guidelines and an assessment of their predictive validity through longitudinal outcome data. Methods: MAB reviews and licensing records for Maryland driver applicants with seizures between 2004 and 2005 were reviewed, during which 254 first-time applicants were processed. The initial licensing decisions were assessed and the subsequent seizure recurrence and crash rates over the following 7 years were evaluated. Results: The MAB approved driving for 74.8% of initial applicants; most had been seizure-free for over 6 months. Approved drivers had a longer median seizure-free period (563 days) compared to those who were denied (104.5 days, p < 0.01), and 22.7% of approved drivers had seizures recur during monitoring over the next year, although none resulted in crashes or deaths. Of applicants initially denied (n = 50), 89.3% were eventually licensed. Treating physicians recommended driving for 84.4% of applicants rejected by the MAB. Significance: Maryland's individualized system for assessing driving applicants with seizures resulted in a dynamic process of approvals and denials based on favorable and unfavorable risk factors and lengths of seizure freedom. Seizure recurrences were comparable to internationally accepted rates. Over the course of monitoring, most applicants were eventually licensed. Treating physicians recommended that nearly all their patient applicants be permitted to drive, which raises safety concerns for the 10 states that rely solely on physician recommendations. Further assessment is needed of the risk factors deemed favorable and unfavorable by the U.S. consensus guidelines.

Original languageEnglish (US)
JournalEpilepsia
DOIs
StateAccepted/In press - 2017

Fingerprint

Epilepsy
Seizures
Guidelines
Licensure
Physicians
Recurrence
Retrospective Studies
Safety

Keywords

  • Consensus guidelines
  • Driving
  • Driving regulation
  • Epilepsy regulation
  • Seizure restriction

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Regulating drivers with epilepsy in Maryland : Results of the application of a United States consensus guideline. / Ma, Brandy B.; Bloch, John; Krumholz, Allan; Hopp, Jennifer L.; Foreman, Perry; Soderstrom, Carl A.; Scottino, Mary A.; Matsumoto, Martha; Krauss, Gregory.

In: Epilepsia, 2017.

Research output: Contribution to journalArticle

Ma, Brandy B. ; Bloch, John ; Krumholz, Allan ; Hopp, Jennifer L. ; Foreman, Perry ; Soderstrom, Carl A. ; Scottino, Mary A. ; Matsumoto, Martha ; Krauss, Gregory. / Regulating drivers with epilepsy in Maryland : Results of the application of a United States consensus guideline. In: Epilepsia. 2017.
@article{c46b8f5b2e20405893bd679cc70e2634,
title = "Regulating drivers with epilepsy in Maryland: Results of the application of a United States consensus guideline",
abstract = "Objective: Driving regulations for people with seizures vary widely throughout the United States and the world. Maryland updated their guidelines in 2003 to reflect those of a U.S. consensus guideline requiring a minimum 3-month seizure-free period as well as an individual risk assessment by a Medical Advisory Board (MAB). This retrospective study provides the first analysis of outcomes after the implementation of the consensus guidelines and an assessment of their predictive validity through longitudinal outcome data. Methods: MAB reviews and licensing records for Maryland driver applicants with seizures between 2004 and 2005 were reviewed, during which 254 first-time applicants were processed. The initial licensing decisions were assessed and the subsequent seizure recurrence and crash rates over the following 7 years were evaluated. Results: The MAB approved driving for 74.8{\%} of initial applicants; most had been seizure-free for over 6 months. Approved drivers had a longer median seizure-free period (563 days) compared to those who were denied (104.5 days, p < 0.01), and 22.7{\%} of approved drivers had seizures recur during monitoring over the next year, although none resulted in crashes or deaths. Of applicants initially denied (n = 50), 89.3{\%} were eventually licensed. Treating physicians recommended driving for 84.4{\%} of applicants rejected by the MAB. Significance: Maryland's individualized system for assessing driving applicants with seizures resulted in a dynamic process of approvals and denials based on favorable and unfavorable risk factors and lengths of seizure freedom. Seizure recurrences were comparable to internationally accepted rates. Over the course of monitoring, most applicants were eventually licensed. Treating physicians recommended that nearly all their patient applicants be permitted to drive, which raises safety concerns for the 10 states that rely solely on physician recommendations. Further assessment is needed of the risk factors deemed favorable and unfavorable by the U.S. consensus guidelines.",
keywords = "Consensus guidelines, Driving, Driving regulation, Epilepsy regulation, Seizure restriction",
author = "Ma, {Brandy B.} and John Bloch and Allan Krumholz and Hopp, {Jennifer L.} and Perry Foreman and Soderstrom, {Carl A.} and Scottino, {Mary A.} and Martha Matsumoto and Gregory Krauss",
year = "2017",
doi = "10.1111/epi.13804",
language = "English (US)",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Regulating drivers with epilepsy in Maryland

T2 - Results of the application of a United States consensus guideline

AU - Ma, Brandy B.

AU - Bloch, John

AU - Krumholz, Allan

AU - Hopp, Jennifer L.

AU - Foreman, Perry

AU - Soderstrom, Carl A.

AU - Scottino, Mary A.

AU - Matsumoto, Martha

AU - Krauss, Gregory

PY - 2017

Y1 - 2017

N2 - Objective: Driving regulations for people with seizures vary widely throughout the United States and the world. Maryland updated their guidelines in 2003 to reflect those of a U.S. consensus guideline requiring a minimum 3-month seizure-free period as well as an individual risk assessment by a Medical Advisory Board (MAB). This retrospective study provides the first analysis of outcomes after the implementation of the consensus guidelines and an assessment of their predictive validity through longitudinal outcome data. Methods: MAB reviews and licensing records for Maryland driver applicants with seizures between 2004 and 2005 were reviewed, during which 254 first-time applicants were processed. The initial licensing decisions were assessed and the subsequent seizure recurrence and crash rates over the following 7 years were evaluated. Results: The MAB approved driving for 74.8% of initial applicants; most had been seizure-free for over 6 months. Approved drivers had a longer median seizure-free period (563 days) compared to those who were denied (104.5 days, p < 0.01), and 22.7% of approved drivers had seizures recur during monitoring over the next year, although none resulted in crashes or deaths. Of applicants initially denied (n = 50), 89.3% were eventually licensed. Treating physicians recommended driving for 84.4% of applicants rejected by the MAB. Significance: Maryland's individualized system for assessing driving applicants with seizures resulted in a dynamic process of approvals and denials based on favorable and unfavorable risk factors and lengths of seizure freedom. Seizure recurrences were comparable to internationally accepted rates. Over the course of monitoring, most applicants were eventually licensed. Treating physicians recommended that nearly all their patient applicants be permitted to drive, which raises safety concerns for the 10 states that rely solely on physician recommendations. Further assessment is needed of the risk factors deemed favorable and unfavorable by the U.S. consensus guidelines.

AB - Objective: Driving regulations for people with seizures vary widely throughout the United States and the world. Maryland updated their guidelines in 2003 to reflect those of a U.S. consensus guideline requiring a minimum 3-month seizure-free period as well as an individual risk assessment by a Medical Advisory Board (MAB). This retrospective study provides the first analysis of outcomes after the implementation of the consensus guidelines and an assessment of their predictive validity through longitudinal outcome data. Methods: MAB reviews and licensing records for Maryland driver applicants with seizures between 2004 and 2005 were reviewed, during which 254 first-time applicants were processed. The initial licensing decisions were assessed and the subsequent seizure recurrence and crash rates over the following 7 years were evaluated. Results: The MAB approved driving for 74.8% of initial applicants; most had been seizure-free for over 6 months. Approved drivers had a longer median seizure-free period (563 days) compared to those who were denied (104.5 days, p < 0.01), and 22.7% of approved drivers had seizures recur during monitoring over the next year, although none resulted in crashes or deaths. Of applicants initially denied (n = 50), 89.3% were eventually licensed. Treating physicians recommended driving for 84.4% of applicants rejected by the MAB. Significance: Maryland's individualized system for assessing driving applicants with seizures resulted in a dynamic process of approvals and denials based on favorable and unfavorable risk factors and lengths of seizure freedom. Seizure recurrences were comparable to internationally accepted rates. Over the course of monitoring, most applicants were eventually licensed. Treating physicians recommended that nearly all their patient applicants be permitted to drive, which raises safety concerns for the 10 states that rely solely on physician recommendations. Further assessment is needed of the risk factors deemed favorable and unfavorable by the U.S. consensus guidelines.

KW - Consensus guidelines

KW - Driving

KW - Driving regulation

KW - Epilepsy regulation

KW - Seizure restriction

UR - http://www.scopus.com/inward/record.url?scp=85020073619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020073619&partnerID=8YFLogxK

U2 - 10.1111/epi.13804

DO - 10.1111/epi.13804

M3 - Article

C2 - 28569419

AN - SCOPUS:85020073619

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

ER -